today's wacc — Biotechnology
8.92%
+ new wacc
224 companies|as of 04/04/2026|gov bond yield: 4.31%|erp: 4.75%|unlevered beta: 0.97|relevered beta: 0.97
allHealthcarePharma & BiotechBiotechnology
Mind Medicine (MindMed)14.03%
CareDx13.94%
Alphamab Oncology13.70%
Everest Medicines13.63%
Inhibrx Biosciences13.51%
Adaptive Biotechnologies13.16%
Kymera Therapeutics13.14%
Oxford Biomedica13.10%
Twist Bioscience12.88%
Kodiak Sciences12.82%
Beam Therapeutics12.82%
Rhythm Pharmaceuticals12.69%
Immunome12.68%
Protagonist Therapeutics12.59%
HBM Holdings12.53%
Sana Biotechnology12.43%
Neuren Pharmaceuticals12.33%
Imeik Technology Development12.31%
Intellia Therapeutics12.20%
Nurix Therapeutics12.15%
Veracyte12.09%
Vitrolife11.77%
CureVac11.60%
CRISPR Therapeutics11.57%
Arcutis Biotherapeutics11.49%
Mabwell (Shanghai) Bioscience11.34%
Staidson (Beijing) BioPharmaceuticals11.32%
WuXi Biologics (Cayman)11.31%
TG Therapeutics11.28%
Natera11.21%
Porton Pharma Solutions11.20%
Pharmaron Beijing11.17%
Wuhan Keqian Biology11.13%
MiMedx Group11.12%
Monte Rosa Therapeutics11.09%
Hualan Biological Bacterin11.06%
Nuvation Bio10.99%
Chengdu Kanghua Biological Products10.95%
Gan & Lee Pharmaceuticals10.94%
Relay Therapeutics10.89%
Cidara Therapeutics10.82%
Amoy Diagnostics10.82%
Aurinia Pharmaceuticals10.71%
BGI Genomics10.71%
Chengdu Olymvax Biopharmaceuticals10.51%
Mesoblast10.48%
Bio-Techne10.47%
Ascletis Pharma10.39%
Vaxcyte10.28%
Immatics10.13%
Moderna10.12%
Anhui Anke Biotechnology (Group)10.10%
Jinyu Bio-technology10.10%
Nuvalent10.03%
Shanghai Allist Pharmaceuticals10.01%
Gubra9.99%
Sunshine Guojian Pharmaceutical (Shanghai)9.99%
Hualan Biological Engineering9.98%
Novo Nordisk9.96%
Dyne Therapeutics9.96%
Hebei Changshan Biochemical Pharmaceutical9.94%
Abbisko Cayman9.93%
Arrowhead Pharmaceuticals9.92%
Chongqing Zhifei Biological Products9.91%
InnoCare Pharma9.85%
Exact Sciences9.84%
Merus9.84%
Anhui Huaheng Biotechnology9.82%
Asymchem Laboratories (Tianjin)9.82%
Nektar Therapeutics9.81%
Dianthus Therapeutics9.78%
CARsgen Therapeutics Holdings9.78%
Vcanbio Cell & Gene Engineering9.77%
Stoke Therapeutics9.76%
Vericel9.72%
Jiangxi Fushine Pharmaceutical9.71%
Roivant Sciences9.71%
Zymeworks9.69%
Ligand Pharmaceuticals9.69%
Celldex Therapeutics9.68%
MoonLake Immunotherapeutics9.66%
Wedge Industrial9.60%
Vera Therapeutics9.59%
Viridian Therapeutics9.59%
3SBio9.56%
Avidity Biosciences9.53%
Sinocelltech Group9.46%
Precigen9.45%
Hunan Jiudian Pharmaceutical9.39%
Insmed9.38%
Denali Therapeutics9.36%
Genus9.33%
Zhejiang Jolly Pharmaceutical9.29%
CStone Pharmaceuticals9.24%
Erasca9.22%
Piramal Pharma9.22%
Suzhou Zelgen Biopharmaceuticals9.19%
MedinCell9.12%
Recursion Pharmaceuticals9.10%
RemeGen9.10%
Revolution Medicines9.10%
Lepu Biopharma9.07%
Beijing Wantai Biological Pharmacy Enterprise9.07%
Shanghai Junshi Biosciences9.06%
Xencor9.03%
Ascentage Pharma8.96%
Tyra Biosciences8.95%
UCB8.94%
Daan Gene8.93%
Financière de Tubize8.93%
Ocular Therapeutix8.91%
BridgeBio Pharma8.91%
Shijiazhuang Yiling Pharmaceutical8.88%
Sinopep-Allsino Bio Pharmaceutical8.87%
Youcare Pharmaceutical Group8.84%
Syngene International8.82%
Beijing Strong Biotechnologies8.80%
Disc Medicine8.77%
Harmony Biosciences Holdings8.71%
Guilin Sanjin Pharmaceutical8.70%
Zealand Pharma8.67%
Tibet Cheezheng Tibetan Medicine8.66%
Sino Biopharmaceutical8.65%
Telix Pharmaceuticals8.64%
Travere Therapeutics8.63%
Incyte8.61%
Arcus Biosciences8.61%
ARS Pharmaceuticals8.60%
Chengzhi Shareholding8.58%
AbCellera Biologics8.57%
ACADIA Pharmaceuticals8.54%
ADMA Biologics8.49%
Oxford Nanopore Technologies8.45%
Shanghai Haohai Biological Technology8.44%
Shanghai Henlius Biotech8.41%
Agios Pharmaceuticals8.38%
Innovent Biologics8.34%
Kuros Biosciences8.29%
Yantai Dongcheng Pharmaceutical Group8.27%
United Therapeutics8.27%
Xenon Pharmaceuticals8.26%
Pharma Mar8.23%
Ardelyx8.23%
argenx8.16%
Genscript Biotech8.14%
Biocytogen Pharmaceuticals (Beijing)8.11%
Halozyme Therapeutics8.06%
Immunovant8.03%
Akeso8.03%
Keymed Biosciences8.03%
Catalyst Pharmaceuticals8.00%
SK bioscience8.00%
China Resources Boya Bio-pharmaceutical Group7.99%
Xiamen Amoytop Biotech7.96%
Tarsus Pharmaceuticals7.89%
Biocon7.86%
Simcere Pharmaceutical Group7.72%
MannKind7.72%
Xeris Biopharma Holdings7.66%
Bonesupport Holding7.62%
Krystal Biotech7.60%
SK Biopharmaceuticals7.55%
Shanghai RAAS Blood Products7.54%
Mirum Pharmaceuticals7.53%
ALK-Abelló7.49%
Haisco Pharmaceutical Group7.46%
Nanobiotix7.41%
Chengdu Easton Biopharmaceuticals7.41%
Axsome Therapeutics7.40%
Inner Mongolia Furui Medical Science7.40%
Cogent Biosciences7.40%
Celltrion7.38%
Beijing Tiantan Biological Products7.38%
Samsung Biologics7.34%
Liquidia7.31%
Amicus Therapeutics7.31%
RAPT Therapeutics7.29%
BioCryst Pharmaceuticals7.27%
Celcuity7.23%
Exelixis7.22%
PTC Therapeutics7.21%
Cytokinetics7.19%
Syndax Pharmaceuticals7.18%
Innoviva7.17%
Ionis Pharmaceuticals7.16%
Regeneron Pharmaceuticals7.15%
Alkermes7.13%
Genmab7.13%
Alnylam Pharmaceuticals7.10%
Vertex Pharmaceuticals7.06%
Camurus7.02%
AnaptysBio7.00%
Laboratorios Farmaceuticos Rovi6.98%
CSL6.97%
Savara6.88%
Crinetics Pharmaceuticals6.86%
BioMarin Pharmaceutical6.82%
Zhejiang Ausun Pharmaceutical6.79%
PeptiDream6.77%
Aurisco Pharmaceutical6.75%
Enliven Therapeutics6.72%
Idorsia6.71%
Corcept Therapeutics6.68%
Sarepta Therapeutics6.68%
Bavarian Nordic6.68%
Edgewise Therapeutics6.68%
Arcellx6.68%
Phathom Pharmaceuticals6.51%
Oculis Holding6.46%
GC Biopharma6.44%
Royalty Pharma6.34%
NewAmsterdam Pharma Company6.31%
Ultragenyx Pharmaceutical6.11%
Kiniksa Pharmaceuticals6.07%
Jazz Pharmaceuticals6.03%
IDEAYA Biosciences5.96%
CK Life Sciences Int'l., (Holdings)5.84%
Galapagos5.36%
Pharming Group5.33%
Apellis Pharmaceuticals5.27%
Amylyx Pharmaceuticals5.22%
Soleno Therapeutics4.76%
Oruka Therapeutics4.23%
Wave Life Sciences1.71%
methodology

WACC is calculated as the weighted average of the cost of equity and the after-tax cost of debt, using median unlevered betas (5-year monthly, adjusted via Blume) relevered with median net-debt capital structures via the Hamada equation.

Cost of equity = risk-free rate + relevered beta × equity risk premium. Cost of debt = (risk-free rate + credit spread) × (1 − tax rate).

Data is updated daily. Read our full methodology on the sources page.